Suvretta Capital Management, LLC Invitae Corp Transaction History

Suvretta Capital Management, LLC

  • $2.54 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$24.31 - $33.6 $41.8 Million - $57.8 Million
-1,719,944 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$26.09 - $40.4 $8.02 Million - $12.4 Million
307,354 Added 21.76%
1,719,944 $58 Million
Q1 2021

May 17, 2021
BUY
$33.06 - $56.93 $46.7 Million - $80.4 Million
1,412,590 New
1,412,590 $54 Million

Others Institutions Holding NVTA

# of Institutions
20
Shares Held
1.92M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Suvretta Capital Management, LLC Portfolio

Follow Suvretta Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email